Nicole Mowad-Nassar
CIK 2084190 · View on SEC EDGAR ↗
Insider
First SEC filing: Nov. 26, 2025 · Latest: Nov. 26, 2025
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 3 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 24, 2025 | RMD | A | 1,331 | $250.52 | $333,442 | 1,331 Direct | — | Acquired | -8.2% (price as of 2026-08-21) |
| Nov. 20, 2025 | RMD | A | 536 | — | — | 777 Direct | +222.41% | Acquired | (price as of 2026-08-21) |
| Sept. 2, 2025 | RMD | A | 241 | — | — | 241 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 24, 2025 | RMD | ResMed Common Stock Options | ResMed Common Stock (1,331) | $250.52 | Nov. 11, 2032 | 1,331 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).